These novel therapies , Tirzepatide , represent a remarkable advancement in addressing type 2 diabetes and possibly related conditions . They all are grouped as GLP-1 pathway stimulators, signifying they to replicate the endogenous GLP-1 substance , stimulating insulin production and lowering foo